IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications.
Saved in:
| Title: | IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications. |
|---|---|
| Authors: | Wu R; Department of Radiation Oncology, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, China.; Graduate School, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, China., Yang H; Department of Radiation Oncology, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, China.; Graduate School, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, China., Liu C; Translational Medicine Research Center, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Feb 24; Vol. 16, pp. 1515718. Date of Electronic Publication: 2025 Feb 24 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1515718 |
